Supplier profile
ASTELLAS PHARMA, S.A.
Every public-sector award we hold for this supplier, across Spain, from 22 Jan 2010 to 8 Sept 2026.
Awards won
258
all time
Attributed value
€215.9m
76 shared, unvalued
Buyers
134
public bodies
Active
2010–2026
first to latest award
Awards by year
Who they win from
| Buyer | Awards | Value |
|---|---|---|
| Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria | 12 | €4.0m |
| Gerencia de Servicio Sanitarios de Fuerteventura | 9 | €591k |
| Consorci de Salut i d'Atenció Social de Catalunya | 8 | not attributable |
| Dirección General de Planificación Económica | 8 | €20.6m |
| Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín | 8 | €1.7m |
| Inspección General de Sanidad de la Defensa | 8 | €421k |
| Servicio Cántabro de Salud | 7 | €4.1m |
| Dirección Gerencia del Complejo Hospitalario Universitario Insular Materno Infantil | 6 | €4.7m |
| Hospital General Universitario Gregorio Marañón | 6 | €2.7m |
| Dirección General de Recursos Económicos del Servicio Canario de la Salud | 5 | €6.8m |
What they win
Awards
Showing 51–75 of 258 awards we hold
- Spain – Pharmaceutical products – SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS CON PRINCIPIOS ACTIVOS ANIFROLUMAB, BENRALIZUMAB, BRENTUXIMAB, BRIGATINIB, DAPAGLIFLOZINA, DARVADSTROCEL, DURVALUMAG, ENFORTUMAB VEDOTINA, ENZALUTAMIDA, FIBRINOGENO HUMANO/TROMBINA, FIDAXOMICINA, GILTERITINIB, IRINOTECAN PEGILADO LIPOSOMAL, MARIBAVIR, OLAPARIB, PEGASPARGASA, TACROLIMUS INTRAVENOSO, TEZEPELUMAB Y VEDOLIZUMAB ↗SERVICIO MURCIANO DE SALUDshared awardawarded 9 Oct 2024
- enzalutamida-xtandi ↗Inspección General de Sanidad de la Defensa€14kawarded 7 Oct 2024
- TA l125 enzalutamida-xtandi ↗Inspección General de Sanidad de la Defensa€51kawarded 7 Oct 2024
- Contrato Basado en Acuerdo Marco para el Suministro de Medicamentos de Uso Humano II. ↗Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín€76kawarded 4 Oct 2024
- Contrato basado en acuerdo marco para el suministro de medicamentos de uso humano II ↗Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín€622kawarded 2 Oct 2024
- Spain – Antineoplastic agents – suministro de diversos medicamentos exclusivos con destino a los centros sanitarios dependientes de la Gerencia Regional de Salud de Castilla y León ↗Gerencia Regional de Salud de Castilla y Leónshared awardawarded 20 Sept 2024
- suministro de diversos medicamentos exclusivos con destino a los centros sanitarios dependientes de la Gerencia Regional de Salud de Castilla y León ↗Gerencia Regional de Salud de Castilla y León€5.8mawarded 19 Sept 2024
- Suministro de medicamentos activos con principios activos anifrolumab, benralizumab, brentuximab, brigatinib, dapagliflozina, fibrinogeno humano/trombina, fidaxomicina, gilteritinib, irinotecan pegilado liposomal, maribavir, olaparib, pegaspargasa, tacrolimus intravenoso ↗Servicio Murciano de Salud - Junta de Compras€7.0mawarded 2 Sept 2024
- Spain – Pharmaceutical products – Establecimiento de un Acuerdo Marco para la homologación de suministradores de medicamentos en el Hospital Intermutual de Levante ↗Gerencia del Hospital Intermutual de Levanteshared awardawarded 22 Aug 2024
- Spain – Various medicinal products – Acuerdo marco del suministro de Medicamentos II ↗Consorci de Salut i d'Atenció Social de Catalunyashared awardawarded 19 Jul 2024
- Spain – Pharmaceutical products – PNSP SUM 24-007 ↗ENTE PUBLICO HOSPITAL UNIVERSITARIO DE FUENLABRADA€140kawarded 2 Jul 2024
- Suministro de Medicamentos de Uso Humano Tipo II ( exclusivos ) , basado en Acuerdo Marco 23/S/20/SU/DG/N/AM08. ↗Gerencia de Servicio Sanitarios de Fuerteventura€68kawarded 18 Jun 2024
- Spain – Pharmaceutical products – Suministro de Enfortumab Vedotina (DOE) ↗OSAKIDETZA - Servicio Vasco de Salud - Organización Central€1.6mawarded 8 Jun 2024
- Suministro del medicamento PADCEV 20 MG. VIAL IV y PADCEV 30 MG. VIAL IV (principio activo ENFORTUMAB VEDOTINA), con destino el Servicio de Farmacia del Hospital Universitario Ntra. Sra. de Candelaria. ↗Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria€92kawarded 5 Jun 2024
- Spain – Antineoplastic agents – PNSP HUPA 39/24 ↗HOSPITAL UNIVERSITARIO PRINCIPE DE ASTURIAS€191kawarded 18 May 2024
- Spain – Pharmaceutical products – SUMINISTRO DE FÁRMACOS EXCLUSIVOS Y/O NO SUSTITUÍBLES ↗Fundació de Gestió Sanitària de l’Hospital de la Santa Creu i Sant Pau.shared awardawarded 6 Mar 2024
- Contrato basado en acuerdo marco para el suministro de medicamentos de uso humano I ↗Dirección Gerencia Hospital Universitario de Gran Canaria Doctor Negrín€42kawarded 24 Jan 2024
- Suministro de Medicamentos de Uso humano tipo II (Exclusivos), con destino al Servicio de Farmacia, derivado de la prórroga del Acuerdo Marco 23/S/20/SU/DG/N/AM08 ↗Dirección Gerente del Hospital Universitario Nuestra Señora de Candelaria€805kawarded 15 Jan 2024
- Spain-Barcelona: Various medicinal products ↗Consorci de Salut i d'Atenció Social de Catalunyashared awardawarded 29 Dec 2023
- Spain-Barcelona: Various medicinal products ↗Consorci de Salut i d'Atenció Social de Catalunyashared awardawarded 26 Dec 2023
- Suministro de medicamentos uso humano II (medicamentos exclusivos ) con destino al Hospital Universitario Dr. José Molina Orosa de Lanzarote, mediante adhesión al acuerdo marco y tramitación anticipada ↗Gerencia de Servicios Sanitarios del Área de Salud de Lanzarote€138kawarded 28 Nov 2023
- Spain – Pharmaceutical products – Suministro de medicamentos exclusivos del área onco/hematología ↗Servicio Cántabro de Salud€1.3mawarded 21 Nov 2023
- Spain-Vitoria-Gasteiz: Pharmaceutical products ↗Dirección General - Osakidetza€11.6mawarded 14 Nov 2023
- Spain-Tortosa: Immunosuppressive agents ↗GESTIO SANITARIA I ASSISTENCIAL DE TORTOSA, S.A.M.shared awardawarded 10 Oct 2023
- Spain-Madrid: Pharmaceutical products ↗SERVICIO MADRILEÑO DE SALUD. Subdirección Gral. Contratación del Servicio Madrileño de Salud.shared awardawarded 13 Sept 2023
Possibly the same organisation
These entries differ from this one only by legal form or a bracketed qualifier, so they may be the same organisation — or a different registered company of the same name. They are kept apart on purpose: the figures on each page are per legal entity and are never combined.
- Astellas Pharma172 awards
- ASTELLAS PHARMA S.P.A.96 awards
- Astellas Pharma s.r.o.32 awards
- Astellas Pharma A/S26 awards
- Astellas Pharma GmbH22 awards
- Astellas Pharma AB20 awards
- Astellas Pharma SAS4 awards
- Astellas Pharma (Alloga)3 awards
- Astellas Pharma (Depolabo)3 awards
- Astellas Pharma (Alloga Marseille)1 award
Bidding against them?
Get new tenders in their space in a daily digest, scored against your own capability — plus the full notice behind each of these awards, with the documents and contacts it published.
Start 7-day free trialHow this profile is built
Awards are collected from official public procurement notices and deduplicated so one procurement counts once. Supplier names are grouped across their published spellings: case and punctuation are ignored, and “Ltd” is treated as optional because buyers routinely leave it off. Everything else that marks a different organisation is kept — an LLP, a plc, a CIC and a Teoranta are separate businesses from a Ltd of the same name, as are a parent and a named subsidiary, and none of them are merged here. Where another entry differs from this one only by legal form or a bracketed qualifier it is listed above as possibly the same organisation — a hint for the reader, never a merge: figures are per legal entity and never combined. Value is attributed only where the notice is explicit: the supplier's own itemised amount, or the whole value where they were the sole named supplier. Awards naming several suppliers without a published split are counted and marked shared, never valued, and a framework ceiling is never treated as money any one appointed supplier won. Sterling and euro are never added together. The linked source notice is authoritative.
Company pages are for organisations. If this page profiles you as an individual — a sole trader or an individual contractor — you can ask for it to be withheld: see how.